Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Pulmonary Function Tests01:25

Pulmonary Function Tests

946
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
946
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.3K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.3K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

751
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
751
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential survival benefit of adjunctive catheter-based embolectomy in high-risk pulmonary embolism patients on veno-arterial extracorporeal membrane oxygenation: A multicenter retrospective study.

International journal of cardiology·2026
Same author

[Relationship between pathogen load kinetics of common Gram-negative bacteria detected by droplet digital polymerase chain reaction and prognosis of patients with suspected bloodstream infections].

Zhonghua wei zhong bing ji jiu yi xue·2026
Same author

Real-time grading method of tunnel surrounding rock based on image recognition.

Frontiers in artificial intelligence·2026
Same author

Clinical Impact of Droplet Digital PCR-Guided Antibiotic Stewardship on Prognosis in Patients with Suspected Bloodstream Infection: A Prospective Observational Study.

Infectious diseases and therapy·2026
Same author

Idebenone protects against doxorubicin-induced cardiac injury by inhibiting ferroptosis in cardiomyocytes.

Experimental gerontology·2026
Same author

Association between serum osmolality trajectories and mortality in sepsis patients: a retrospective multi-cohort study.

European journal of medical research·2025

Related Experiment Video

Updated: Mar 8, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

16.6K

Pulmonary Function and Arterial Stiffness in Chronic Heart Failure.

Li Li1, Bangchuan Hu2, Shijin Gong1

  • 1Intensive Care Unit and Zhejiang Provincial Key Laboratory of Geriatrics, Zhejiang Hospital, 12 Lingyin Road, Hangzhou 310013, China.

Biomed Research International
|January 19, 2017
PubMed
Summary

Reduced lung function is linked to increased arterial stiffness in heart failure patients. Angiotensin receptor blockers (ARBs) were associated with arterial stiffness, suggesting potential therapeutic targets for improving heart failure prognosis.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.7K

Related Experiment Videos

Last Updated: Mar 8, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

16.6K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.7K

Area of Science:

  • Cardiology
  • Pulmonology
  • Pharmacology

Background:

  • Arterial stiffness is a significant contributor to heart failure development and progression.
  • Angiotensin receptor blockers (ARBs) have demonstrated a capacity to reduce arterial stiffness.
  • The interplay between pulmonary function, arterial stiffness, and heart failure requires further elucidation.

Purpose of the Study:

  • To investigate the association between lung function parameters and arterial stiffness in patients with chronic heart failure.
  • To examine the relationship between the use of angiotensin receptor blockers (ARBs) and arterial stiffness in this patient cohort.

Main Methods:

  • Cross-sectional study involving 354 outpatients diagnosed with chronic heart failure.
  • Assessment of lung function parameters: forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and FEV1/FVC ratio.
  • Measurement of arterial stiffness using the cardio-ankle vascular index (CAVI).

Main Results:

  • A significant negative correlation was observed between forced expiratory volume in 1 second (FEV1) and cardio-ankle vascular index (CAVI) (r = -0.2987, p < 0.0001).
  • Angiotensin receptor blockers (ARBs) showed a positive association with CAVI, while ACE inhibitors (ACEI) did not.
  • Multiple regression analysis identified ARB use and lower FEV1 as independent predictors of increased arterial stiffness (CAVI).

Conclusions:

  • Reduced pulmonary function, specifically lower FEV1, is significantly associated with increased arterial stiffness in patients with chronic heart failure.
  • The use of ARBs is independently associated with higher arterial stiffness in this population.
  • Pulmonary function may serve as a modifiable factor for improving cardiovascular outcomes in heart failure, warranting further investigation.